KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2025)

Hims & Hers Health's Accumulated Expenses history spans 7 years, with the latest figure at $78.5 million for Q4 2025.

  • For Q4 2025, Accumulated Expenses rose 48.11% year-over-year to $78.5 million; the TTM value through Dec 2025 reached $78.5 million, up 48.11%, while the annual FY2025 figure was $78.5 million, 48.11% up from the prior year.
  • Accumulated Expenses for Q4 2025 was $78.5 million at Hims & Hers Health, down from $80.1 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $80.1 million in Q3 2025 and bottomed at $5.8 million in Q1 2021.
  • The 5-year median for Accumulated Expenses is $23.2 million (2023), against an average of $30.7 million.
  • The largest annual shift saw Accumulated Expenses skyrocketed 1908.2% in 2021 before it grew 2.08% in 2022.
  • A 5-year view of Accumulated Expenses shows it stood at $12.2 million in 2021, then rose by 2.08% to $12.4 million in 2022, then skyrocketed by 132.74% to $29.0 million in 2023, then soared by 82.98% to $53.0 million in 2024, then soared by 48.11% to $78.5 million in 2025.
  • Per Business Quant, the three most recent readings for HIMS's Accumulated Expenses are $78.5 million (Q4 2025), $80.1 million (Q3 2025), and $65.7 million (Q2 2025).